Differential regulation of albumin gene expression by heparin-binding epidermal growth factor-like growth factor in α-fetoprotein-producing and - nonproducing human hepatoma cells

Tumor Biology

Volumn 20, Issue 3, 1999, Pages 130-138

  Ishikawa, Hiroki ^a   Nakata, Keisuke ^a   Tsuruta, Shotaro ^a   Nakao, Kazuhiko ^b   Kato, Yuji ^a   Tamaoki, Taiki ^c   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Nagasaki University of Medicine ^*

Author keywords

Albumin; HB EGF; Silencer; Fetoprotein

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; DOWN REGULATION; ENHANCER REGION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSDUCTION; HEPATOMA CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM;

EID: 0032951908     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030055     Document Type: Article

References (34)

1. Nahon JL: The regulation of albumin and alpha-fetoprotein gene expression in mammals. Biochimie 1987;69:445-459.
2. Tilghman SM, Belayew A: Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc Natl Acad Sci USA 1982;79:5254-5257.
3. Urano Y, Sakai M, Watanabe K, Tamaoki T: Tandem arrangement of the albumin and alpha-fetoprotein genes in the human genome. Gene 1984;32:255-261.
4. Alpert ME, Uriel J, de Nechaud B: Alpha-1 fetoglobulin in the diagnosis of human hepatoma. N Engl J Med 1968;278:984-986.
5. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, Endo Y, Nagataki S: Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993;328:1802-1806.
6. Nakata K, Motomura M, Nakabayashi H, Ido A, Tamaoki T: A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol ester. J Biol Chem 1992; 267:1331-1334.
7. Vacher J, Tilghman SM: Dominant negative regulation of the mouse alpha-fetoprotein gene in adult liver. Science 1990;250:1732-1735.
8. Nakabayashi H, Hashimoto T, Miyao Y, Tjong KK, Chan J, Tamaoki T: A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma. Mol Cell Biol 1991; 11:5885-5893.
9. Hatano M, Nakata K, Nakao K, Tsutsumi T, Ohtsuru A, Nakamura T, Tamaoki T, Nagataki S: Hepatocyte growth factor down-regulates the alpha-fetoprotein gene expression in PLC/PRF/5 human hepatoma cells. Biochem Biophys Res Commun 1992;189:385-391.
10. Nakabayashi H, Watanabe K, Saito A, Ohtsuru A, Sawadaishi K, Tamaoki T: Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells. J Biol Chem 1989;264:266-271.
11. Nakao K, Nakata K, Mitsuoka S, Ohtsuru A, Ido A, Hatano M, Sato Y, Nakayama T, Shima M, Kusumoto Y, Koji T, Tamaoki T: Transforming growth factor beta 1 differentially regulates alpha-fetoprotein and albumin in HuH-7 human hepatoma cells. Biochem Biophys Res Commun 1991;174:1294-1299; erratum in Biochem Biophys Res Commun 1991 Mar 29;175:1165.
12. Tsutsumi T, Ido A, Nakao K, Hamasaki K, Kato Y, Ohtsuru A, Nakata K, Tamaoki T, Nagataki S: Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells. Gastroenterology 1994;107:499-504.
13. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M: A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;251: 936-939.
14. Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M: Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 1992;267:6205-6212.
15. Higashiyama S, Abraham JA, Klagsbrun M: Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate. J Cell Biol 1993;122: 933-940.
16. Kobrin MS, Funatomi H, Friess H, Buchler MW, Stathis P, Korc M: Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994; 202:1705-1709.
17. Miyazaki Y, Shinomura Y, Higashiyama S, Kanayama S, Higashimoto Y, Tsutsui S, Zushi S, Taniguchi N, Matsuzawa Y: Heparin-binding EGF-like growth factor is an autocrine growth factor for rat gastric epithelial cells. Biochem Biophys Res Commun 1996;223:36-41.
18. Inui Y, Higashiyama S, Kawata S, Tamura S, Miyagawa J, Taniguchi N, Matsuzawa Y: Expression of heparm-binding epidermal growth factor in human hepatocellular carcinoma. Gastroenterology 1994;107: 1799-1804.
19. Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, Sato J: Phenotypical stability of a human hepatoma cell line, HuH-7, in longterm culture with chemically defined medium. Gann 1984;75:151-158.
20. Knook DL, Blansjaar N, Sleyster EC: Isolation and characterization of Kupffer and endothelial cells from the rat liver. Exp Cell Res 1977;109:317-329.
21. Morinaga T, Sakai M, Wegmann TG, Tamaoki T: Primary structures of human alpha-fetoprotein and its mRNA. Proc Natl Acad Sci USA 1983;80:4604-4608.
22. Watanabe K, Saito A, Tamaoki T: Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene. J Biol Chem 1987;262:4812-4818.
23. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M: Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413-7417.
24. Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982;2:1044-1051.
25. Miyoshi E, Higashiyama S, Nakagawa T, Hayashi N, Taniguchi N: Membrane-anchored heparin-binding epidermal growth factor-like growth factor acts as a tumor survival factor in a hepatoma cell line. J Biol Chem 1997;272:14349-14355.
26. Verde P, Boast S, Franze A, Robbiati F, Blasi F: An upstream enhancer and a negative element in the 5′-fIanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res 1988;16:10699-10716.
27. Sato K, Ito K, Kohara H, Yamaguchi Y, Adachi K, Endo H: Negative regulation of catalase gene expression in hepatoma cells. Mol Cell Biol 1992;12:2525-2533.
28. Lin HK, Penning TM: Cloning, sequencing, and functional analysis of the 5′-flanking region of the rat 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase gene. Cancer Res 1995;55:4105-4113.
29. Lupo A, Costanzo P, Medugno L, Salvatore F, Izzo P: Characterization of a silencer that modulates transcription of the human distal aldolase A promoter. Biochem Biophys Res Commun 1995;216:69-77.
30. Rieckmann P, Wilson GL, Thevenin C, Hong JX, Kehrl JH: Analysis of cis-acting elements present in the CD20/B1 antigen promoter. J Immunol 1991;147:3994-3999.
31. Ptashne M: Gene regulation by proteins acting nearby and at a distance. Nature 1986;322:697-701.
32. Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S: Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res 1995;55:3105-3109.
33. Kanai F, Lan KH, Shiratori Y, Tanaka T, Ohashi M, Okudaira T, Yoshida Y, Wakimoto H, Hamada H, Nakabayashi H, Tamaoki T, Omata M: In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res 1997;57:461-465.
34. Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, Chiang YL: Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 1995;55:5283-5287.